Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
about
Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.Delivery of novel macromolecular drugs against HIV-1.Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.New modalities in oncology: ribozymes.
P2860
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
@ast
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
@en
type
label
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
@ast
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
@en
prefLabel
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
@ast
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
@en
P2093
P2860
P1476
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1992.TB21062.X
P407
P577
1992-10-01T00:00:00Z